Union européenne - islandais - EMA (European Medicines Agency)

chiesi farmaceutici s.p.a - levofloxacin - cystic fibrosis; respiratory tract infections - sýklalyf fyrir almenn nota, - quinsair er ætlað fyrir stjórnun langvarandi lungum sýkingum vegna pseudomonas tilhneiging til að hætta í fullorðinn sjúklingar fengið lungnasjúkdóm. Íhuga ætti að opinbera leiðsögn á réttri notkun af sýklalyfjum.

Union européenne - islandais - EMA (European Medicines Agency)

a. menarini industrie farmaceutiche riunite s.r.l. - delafloxacin meglúmíni - samfarir í bandalaginu - sýklalyf fyrir almenn nota, - quofenix is indicated for the treatment of the following infections in adults:acute bacterial skin and skin structure infections (absssi),community-acquired pneumonia (cap), when it is considered inappropriate to use other antibacterial agents that are commonly recommended for the initial treatment of these infections (see sections 4. 4 og 5. Íhuga ætti að opinbera leiðsögn á réttri notkun af sýklalyfjum.

Union européenne - islandais - EMA (European Medicines Agency)

biomarin international limited - vosoritide - achondroplasia - lyf til að meðhöndla beinsjúkdóma - voxzogo is indicated for the treatment of achondroplasia in patients 4 months of age and older whose epiphyses are not closed. the diagnosis of achondroplasia should be confirmed by appropriate genetic testing.

Islande - islandais - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - rosuvastatinum kalsíum - filmuhúðuð tafla - 20 mg

Islande - islandais - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - rosuvastatinum kalsíum - filmuhúðuð tafla - 10 mg

Islande - islandais - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - rosuvastatinum kalsíum - filmuhúðuð tafla - 5 mg

Islande - islandais - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - rosuvastatinum kalsíum - filmuhúðuð tafla - 40 mg

Union européenne - islandais - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - dauða - mergæxli - Ónæmisbælandi lyf - thalidomide bms in combination with melphalan and prednisone as first line treatment of patients with untreated multiple myeloma, aged >/= 65 years or ineligible for high dose chemotherapy. thalidomide bms is prescribed and dispensed according to the thalidomide celgene pregnancy prevention programme (see section 4.

Union européenne - islandais - EMA (European Medicines Agency)

lipomed gmbh - dauða - mergæxli - Ónæmisbælandi lyf - thalidomide lipomed in combination with melphalan and prednisone is indicated as first line treatment of patients with untreated multiple myeloma, aged ≥ 65 years or ineligible for high dose chemotherapy. thalidomide lipomed is prescribed and dispensed in accordance with the thalidomide lipomed pregnancy prevention programme (see section 4.

Islande - islandais - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley with subfirm xiromed - atorvastatin kalsíum tríhýdrat - filmuhúðuð tafla - 80 mg